Medytox Inc.

South Korean manufacturer Medytox Inc. was established in 2006 and has since then registered rapid growth. The company has cemented its place in the medical aesthetic markets as one of the biggest producers of botulinum toxin type A products, supplying domestically in South Korea, as well as in Europe and the US. Medytox is constantly in the process of developing new types of botulinum toxins and aims to become a global biopharmaceutical leader with a 10% global market share.